FDA Response Confirms Senators On Right Trail About N.Y. Herbal Product Tests
This article was originally published in The Tan Sheet
“FDA does not use DNA sequencing by itself to analyze an herbal extract for phytochemicals,” Associate Commissioner for Legislation Thomas Kraus tells Senators Hatch and Heinrich. The senators gave FDA an opportunity, without asking for a comment on an ongoing New York investigation, to describe the agency’s regulation of supplement manufacturing.
You may also be interested in...
NBTY notes that FDA regulations allow firms flexibility in test methodologies for ingredient identity and other testing required under the supplement GMP final rule, and industry stakeholders say compliance with the GMPs is the standard, not a state agency's preferences.